Clinical Trials Browser

Phase 1 × Completed × uproleselan × Clear all

NCT04839341 2025-06-27

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute